Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer
NCT03065010
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
BCD-115
Sponsor
Biocad